Table 2. Structural attributes of predictive motif elements.
Site no. | Max no. | Site | Motif? | Max | Structural explanation | Myc | Mismatch | Site no. | Mad | Site no. |
---|---|---|---|---|---|---|---|---|---|---|
1 | 24 | B1 | Y | K | Contacts DNA (A7'); beginning of Basic region | K | 355 | S | 57 | |
2 | 25 | B2 | Y | R | Contacts phosphate backbone | R | 356 | R | 58 | |
3 | 26 | B3 | Y | A | R | 2 | 357 | S | 59 | |
4 | 27 | B4 | H | T | 358 | T | 60 | |||
5 | 28 | B5 | Y | H | Contacts DNA (G3'); bHLH group designation | H | 1 | 359 | H | 61 |
6 | 29 | B6 | Y | N | Contacts phosphate backbone | N | 4 | 360 | N | 62 |
7 | 30 | B7 | A | V | 361 | E | 63 | |||
8 | 31 | B8 | Y | L | L | 1 | 362 | M | 64 | |
9 | 32 | B9 | Y | E | Contact with DNA (C3 and A2) | E | 363 | E | 65 | |
10 | 33 | B10 | Y | R | Contacts phosphate backbone | R | 364 | K | 66 | |
11 | 34 | B11 | K | Q | 365 | N | 67 | |||
12 | 35 | B12 | Y | R | Contacts phosphate backbone | R | 2 | 366 | R | 68 |
13 | 36 | B13 | Y | R | Contacts DNA and phosphate backbone | R | 3 | 367 | R | 69 |
14 | 37 | H1 | D | N | 368 | A | 70 | |||
15 | 38 | H2 | Y | H | E | 369 | H | 71 | ||
16 | 39 | H3 | Y | I | Side chain packs against F43; buried site | L | 2 | 370 | L | 72 |
17 | 40 | H4 | Y | K | K | 371 | R | 73 | ||
18 | 41 | H5 | D | R | 372 | L | 74 | |||
19 | 42 | H6 | S | S | 373 | C | 75 | |||
20 | 43 | H7 | Y | F | Many Van der Waals contacts with H2 side chains; buried site | F | 374 | L | 76 | |
21 | 44 | H8 | H | F | 375 | E | 77 | |||
22 | 45 | H9 | S | A | 376 | K | 78 | |||
23 | 46 | H10 | Y | L | Packs against 63 and 67; buried site | L | 377 | L | 79 | |
24 | 47 | H11 | Y | R | R | 378 | K | 80 | ||
25 | 48 | H12 | Y | D | D | 379 | G | 81 | ||
26 | 49 | H13 | S | Q | 380 | L | 82 | |||
27 | 50 | H14 | V | Packs against 70 | 1 | 381 | V | 83 | ||
28 | 51 | H15 | Y | P | End of Helix 1; P residue turns strand; packs against 70; buried site | P | 2 | 382 | P | 84 |
Explanations are based on Ferre-D'Amare et al. (21) for Max. The numbering schemes are based on the human sequences for the Max, Myc, and Mad proteins.